Stock listing

Remegen Co. Ltd. Class A

Selected listing: A2QGM4 · LSX · EUR · DE

Remegen Co. Ltd. Class A (LS Exchange: A2QGM4), Health Technology. Latest release Sep 8, 2026: "REMEGEN CO., LTD."Announcement on Participating in the 2026…

A2QGM4:LSXEURDEUpdated September 25, 2026

Ticker: LS Exchange: A2QGM4
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Remegen Co. Ltd. Class A

The company is involved in the biopharmaceutical sector, focusing on the development and commercialization of innovative therapies. Remegen aims to address unmet medical needs through its research and product offerings.

Latest news from Remegen Co. Ltd. Class A

"REMEGEN CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

September 7, 2026

"REMEGEN CO., LTD."Announcement on Adjustment of Members of Special Committees of the Board of Directors

August 24, 2026

"REMEGEN CO., LTD."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026

August 5, 2026

"REMEGEN CO., LTD."Announcement on Progress of the First Repurchase of Company Shares in 2026 through Call Auction

August 3, 2026

"REMEGEN CO., LTD."Announcement on the First Share Repurchase through Call Auction in 2026

July 30, 2026

All Remegen Co. Ltd. Class A news →

Research Remegen Co. Ltd. Class A

Remegen Co. Ltd. Class A company profile

View the public company page for Remegen Co. Ltd. Class A on 6ix.

Remegen Co. Ltd. Class A news

Read company news and market updates connected to Remegen Co. Ltd. Class A.

Remegen Co. Ltd. Class A investor events

Find investor webinars, events, and replay context for Remegen Co. Ltd. Class A.